Third Circuit Affirms Denial of Stelara Biosimilar Injunction
Big Molecule Watch
As previously reported, litigation between Johnson Johnson and Janssen ("J J") and Samsung Bioepis ("Samsung") involving Samsung's Stelara biosimilar, PYZCHIVA (ustekinumab-ttwe) (previously known as
pharminent
May 11, 2026 (Last updated: May 12, 2026)
Big Molecule Watch
As previously reported, litigation between Johnson Johnson and Janssen (“J J”) and Samsung Bioepis (“Samsung”) involving Samsung’s Stelara biosimilar, PYZCHIVA (ustekinumab-ttwe) (previously known as
